FDA Inspection 1038527 — Orit Freedman
The FDA completed an inspection of Orit Freedman on Dec 21, 2017 in Oshawa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 21, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oshawa (Canada)
Additional Details
Clinical Investigator (CI)